Session » 4M103 ACR Abstract: Pain Mechanisms–Basic & Clinical Science (1917–1922)

Date: Monday, October 22, 2018

Time: 4:30PM-6:00PM

Meeting: 2018 ACR/ARHP Annual Meeting

4:30PM-6:00PM: Abstract Number: 1922

Characterization of the Pharmacology and Pharmacokinetics of Cntx-4975, a High-Purity, Synthetic Trans-Capsaicin in Clinical Development for the Treatment of Moderate to Severe OA Knee Pain

4:30PM-6:00PM: Abstract Number: 1918

Defining Pain That Does Not Interfere with Activities Among Rheumatoid Arthritis (RA) Patients

4:30PM-6:00PM: Abstract Number: 1919

Individual Short-Acting Opioids and the Risk of Opioid-Related Adverse Events in Adolescents

4:30PM-6:00PM: Abstract Number: 1920

Is There Objective Evidence of Neuropathy in Knee Osteoarthritis Based on Clinical Evaluation?

4:30PM-6:00PM: Abstract Number: 1917

Physician Opioid Prescribing Patterns and Risk for Chronic Opioid Use Among Rheumatoid Arthritis Patients

4:30PM-6:00PM: Abstract Number: 1921

Relation of Sensitization and Conditioned Pain Modulation to Post-Knee Replacement Pain

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].